Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.110
-0.030 (-2.64%)
Nov 4, 2024, 4:00 PM EST - Market closed
Processa Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -11.53 | -11.12 | -27.42 | -11.43 | -14.41 | -3.36 | |
Depreciation & Amortization | 0 | 0 | 0.79 | 0.79 | 0.8 | 0.8 | |
Other Amortization | - | - | 0.12 | - | 0.2 | 0 | |
Asset Writedown & Restructuring Costs | - | - | 7.27 | 0.3 | 8.6 | - | |
Stock-Based Compensation | 0.73 | 1.06 | 8.83 | 3.41 | 2.73 | 0.51 | |
Other Operating Activities | 0.09 | 1.39 | 0.27 | -0.61 | -0.92 | -0.53 | |
Change in Accounts Receivable | - | - | 0.07 | 0.01 | -0.08 | - | |
Change in Accounts Payable | 0.37 | -0.02 | 0.11 | -0.1 | 0.25 | -0.22 | |
Change in Other Net Operating Assets | -0.78 | 0.62 | 0.36 | -1.08 | -0.31 | 0.04 | |
Operating Cash Flow | -11.12 | -8.06 | -9.61 | -8.72 | -3.14 | -2.75 | |
Capital Expenditures | -0 | -0 | - | - | - | - | |
Investing Cash Flow | -0 | -0 | - | - | - | - | |
Short-Term Debt Issued | - | - | - | - | 0.7 | 0.81 | |
Long-Term Debt Issued | - | - | - | - | 0.16 | - | |
Total Debt Issued | - | - | - | - | 0.86 | 0.81 | |
Net Debt Issued (Repaid) | -0 | - | - | - | 0.86 | 0.81 | |
Issuance of Common Stock | 7.18 | 6.32 | - | 10.05 | 17.1 | 0.9 | |
Repurchase of Common Stock | -0.02 | -0.05 | -0.39 | -0.06 | -0.1 | - | |
Other Financing Activities | - | - | - | -0.19 | - | -0 | |
Financing Cash Flow | 7.16 | 6.27 | -0.39 | 9.8 | 17.87 | 1.7 | |
Net Cash Flow | -3.97 | -1.8 | -9.99 | 1.08 | 14.72 | -1.05 | |
Free Cash Flow | -11.12 | -8.07 | -9.61 | -8.72 | -3.14 | -2.75 | |
Free Cash Flow Per Share | -4.39 | -6.15 | -11.92 | -11.38 | -8.38 | -9.95 | |
Levered Free Cash Flow | -5.52 | -4.11 | -2.96 | -4.19 | -0.23 | -1.31 | |
Unlevered Free Cash Flow | -5.52 | -4.11 | -3.08 | -4.19 | -0.25 | -1.29 | |
Change in Net Working Capital | 0.52 | -0.68 | 0.03 | 1.16 | -0.23 | 0.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.